Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01AC Oxicams
M01AC05 Lornoxicam
D01866 Lornoxicam (JP18/USAN/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
114 Antipyretics and analgesics, anti-inflammatory agents
1149 Others
D01866 Lornoxicam (JP18/USAN/INN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01910 Anti-inflammatory drug, oxicams
D01866 Lornoxicam
DG01922 Selective COX2 inhibitor
D01866 Lornoxicam
Metabolizing enzyme substrate
DG01642 CYP2C9 substrate
D01866 Lornoxicam
Drug classes [BR:br08332]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
D01866 Lornoxicam
D01866 Lornoxicam
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Prostaglandin synthase
PTGS1 (COX1)
D01866 Lornoxicam (JP18/USAN/INN) <JP>
PTGS2 (COX2)
D01866 Lornoxicam (JP18/USAN/INN) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01866 Lornoxicam
D01866 Lornoxicam tablets
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01866
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01866